Cargando…

Nedd4 ubiquitylates VDAC2/3 to suppress erastin-induced ferroptosis in melanoma

Ferroptosis is a newly defined form of regulated cell death characterized by the iron-dependent accumulation of lipid hydroperoxides. Erastin, the ferroptosis activator, binds to voltage-dependent anion channels VDAC2 and VDCA3, but treatment with erastin can result in the degradation of the channel...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yongfei, Luo, Meiying, Zhang, Kexin, Zhang, Jun, Gao, Tongtong, Connell, Douglas O’, Yao, Fengping, Mu, Changwen, Cai, Bingyu, Shang, Yuxue, Chen, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6978386/
https://www.ncbi.nlm.nih.gov/pubmed/31974380
http://dx.doi.org/10.1038/s41467-020-14324-x
_version_ 1783490688374013952
author Yang, Yongfei
Luo, Meiying
Zhang, Kexin
Zhang, Jun
Gao, Tongtong
Connell, Douglas O’
Yao, Fengping
Mu, Changwen
Cai, Bingyu
Shang, Yuxue
Chen, Wei
author_facet Yang, Yongfei
Luo, Meiying
Zhang, Kexin
Zhang, Jun
Gao, Tongtong
Connell, Douglas O’
Yao, Fengping
Mu, Changwen
Cai, Bingyu
Shang, Yuxue
Chen, Wei
author_sort Yang, Yongfei
collection PubMed
description Ferroptosis is a newly defined form of regulated cell death characterized by the iron-dependent accumulation of lipid hydroperoxides. Erastin, the ferroptosis activator, binds to voltage-dependent anion channels VDAC2 and VDCA3, but treatment with erastin can result in the degradation of the channels. Here, the authors show that Nedd4 is induced following erastin treatment, which leads to the ubiquitination and subsequent degradation of the channels. Depletion of Nedd4 limits the protein degradation of VDAC2/3, which increases the sensitivity of cancer cells to erastin. By understanding the molecular mechanism of erastin-induced cellular resistance, we can discover how cells adapt to new molecules to maintain homeostasis. Furthermore, erastin-induced resistance mediated by FOXM1-Nedd4-VDAC2/3 negative feedback loop provides an initial framework for creating avenues to overcome the drug resistance of ferroptosis activators.
format Online
Article
Text
id pubmed-6978386
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-69783862020-01-27 Nedd4 ubiquitylates VDAC2/3 to suppress erastin-induced ferroptosis in melanoma Yang, Yongfei Luo, Meiying Zhang, Kexin Zhang, Jun Gao, Tongtong Connell, Douglas O’ Yao, Fengping Mu, Changwen Cai, Bingyu Shang, Yuxue Chen, Wei Nat Commun Article Ferroptosis is a newly defined form of regulated cell death characterized by the iron-dependent accumulation of lipid hydroperoxides. Erastin, the ferroptosis activator, binds to voltage-dependent anion channels VDAC2 and VDCA3, but treatment with erastin can result in the degradation of the channels. Here, the authors show that Nedd4 is induced following erastin treatment, which leads to the ubiquitination and subsequent degradation of the channels. Depletion of Nedd4 limits the protein degradation of VDAC2/3, which increases the sensitivity of cancer cells to erastin. By understanding the molecular mechanism of erastin-induced cellular resistance, we can discover how cells adapt to new molecules to maintain homeostasis. Furthermore, erastin-induced resistance mediated by FOXM1-Nedd4-VDAC2/3 negative feedback loop provides an initial framework for creating avenues to overcome the drug resistance of ferroptosis activators. Nature Publishing Group UK 2020-01-23 /pmc/articles/PMC6978386/ /pubmed/31974380 http://dx.doi.org/10.1038/s41467-020-14324-x Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Yang, Yongfei
Luo, Meiying
Zhang, Kexin
Zhang, Jun
Gao, Tongtong
Connell, Douglas O’
Yao, Fengping
Mu, Changwen
Cai, Bingyu
Shang, Yuxue
Chen, Wei
Nedd4 ubiquitylates VDAC2/3 to suppress erastin-induced ferroptosis in melanoma
title Nedd4 ubiquitylates VDAC2/3 to suppress erastin-induced ferroptosis in melanoma
title_full Nedd4 ubiquitylates VDAC2/3 to suppress erastin-induced ferroptosis in melanoma
title_fullStr Nedd4 ubiquitylates VDAC2/3 to suppress erastin-induced ferroptosis in melanoma
title_full_unstemmed Nedd4 ubiquitylates VDAC2/3 to suppress erastin-induced ferroptosis in melanoma
title_short Nedd4 ubiquitylates VDAC2/3 to suppress erastin-induced ferroptosis in melanoma
title_sort nedd4 ubiquitylates vdac2/3 to suppress erastin-induced ferroptosis in melanoma
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6978386/
https://www.ncbi.nlm.nih.gov/pubmed/31974380
http://dx.doi.org/10.1038/s41467-020-14324-x
work_keys_str_mv AT yangyongfei nedd4ubiquitylatesvdac23tosuppresserastininducedferroptosisinmelanoma
AT luomeiying nedd4ubiquitylatesvdac23tosuppresserastininducedferroptosisinmelanoma
AT zhangkexin nedd4ubiquitylatesvdac23tosuppresserastininducedferroptosisinmelanoma
AT zhangjun nedd4ubiquitylatesvdac23tosuppresserastininducedferroptosisinmelanoma
AT gaotongtong nedd4ubiquitylatesvdac23tosuppresserastininducedferroptosisinmelanoma
AT connelldouglaso nedd4ubiquitylatesvdac23tosuppresserastininducedferroptosisinmelanoma
AT yaofengping nedd4ubiquitylatesvdac23tosuppresserastininducedferroptosisinmelanoma
AT muchangwen nedd4ubiquitylatesvdac23tosuppresserastininducedferroptosisinmelanoma
AT caibingyu nedd4ubiquitylatesvdac23tosuppresserastininducedferroptosisinmelanoma
AT shangyuxue nedd4ubiquitylatesvdac23tosuppresserastininducedferroptosisinmelanoma
AT chenwei nedd4ubiquitylatesvdac23tosuppresserastininducedferroptosisinmelanoma